Jazz Pharmaceuticals plc
JAZZ· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Revenue | $232.16M | $175.52M | $73.29M | $73.29M |
| Net Income | $75.41M | $33.21M | $32.48M | $32.48M |
| EPS Diluted | $1.23 |
Jazz Pharmaceuticals plc · CIK 1232524 · Engraved from SEC EDGAR
| $0.55 |
| $0.69 |
| $0.69 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.